{"log_id": 3087532614037893693, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 4.5e-05, "average": 0.991766, "min": 0.978959}, "location": {"width": 133, "top": 121, "height": 29, "left": 130}, "words": "【用法用量】"}, {"probability": {"variance": 6e-06, "average": 0.998443, "min": 0.98942}, "location": {"width": 371, "top": 169, "height": 30, "left": 120}, "words": "本品应在有经验的医生指导下使用"}, {"probability": {"variance": 9.7e-05, "average": 0.995164, "min": 0.969357}, "location": {"width": 322, "top": 219, "height": 28, "left": 168}, "words": "推荐剂量:850mg,每日1次"}, {"probability": {"variance": 9.4e-05, "average": 0.996815, "min": 0.939449}, "location": {"width": 945, "top": 266, "height": 38, "left": 168}, "words": "服用方法:口服,餐后半小时服用(每日服药的时间应尽可能相同),以温开水送服。疗"}, {"probability": {"variance": 2.3e-05, "average": 0.997688, "min": 0.980593}, "location": {"width": 369, "top": 316, "height": 29, "left": 120}, "words": "程中漏服阿帕替尼的剂量不能补充"}, {"probability": {"variance": 0, "average": 0.99956, "min": 0.998297}, "location": {"width": 689, "top": 364, "height": 31, "left": 167}, "words": "治疗时间:连续服用,直至疾病进展或出现不可耐受的不良反应"}, {"probability": {"variance": 1e-06, "average": 0.99858, "min": 0.99635}, "location": {"width": 275, "top": 412, "height": 29, "left": 166}, "words": "肝肾功能不全患者的用药"}, {"probability": {"variance": 2.5e-05, "average": 0.997915, "min": 0.973748}, "location": {"width": 946, "top": 459, "height": 36, "left": 167}, "words": "目前尚无本品对肝肾功能不全患者影响的相关数据,建议肝肾功能不全患者应根据临床情"}, {"probability": {"variance": 9e-06, "average": 0.998407, "min": 0.987577}, "location": {"width": 785, "top": 509, "height": 32, "left": 120}, "words": "况和实验室检查指标在医师指导下慎用本品,重度肝肾功能不全患者禁用"}, {"probability": {"variance": 8e-06, "average": 0.997484, "min": 0.992966}, "location": {"width": 99, "top": 556, "height": 30, "left": 165}, "words": "剂量调整"}, {"probability": {"variance": 7e-06, "average": 0.998839, "min": 0.988962}, "location": {"width": 949, "top": 602, "height": 39, "left": 163}, "words": "在本品使用过程中应密切监测不良反应,并根据需要进行调整以使患者能够耐受治疗。阿帕替尼"}, {"probability": {"variance": 6.4e-05, "average": 0.997084, "min": 0.949685}, "location": {"width": 994, "top": 651, "height": 35, "left": 117}, "words": "所致的不良反应可通过对症治疗、停药和调整剂量等方式处理。临床研究中剂量调整多发生在第2、3个"}, {"probability": {"variance": 1.8e-05, "average": 0.996831, "min": 0.985786}, "location": {"width": 210, "top": 701, "height": 26, "left": 121}, "words": "周期(28天为一周期)"}, {"probability": {"variance": 0.007806, "average": 0.983995, "min": 0.432736}, "location": {"width": 944, "top": 746, "height": 34, "left": 165}, "words": "当患者出现34级血液学或非血液学不良反应时,建议暂停用药(不超过2周)直至症状"}, {"probability": {"variance": 1.7e-05, "average": 0.998534, "min": 0.976527}, "location": {"width": 993, "top": 792, "height": 35, "left": 116}, "words": "缓解或消失,随后继续按原剂量服用;若2周后不良反应仍未缓解,建议在医师指导下调整剂"}, {"probability": {"variance": 0.004763, "average": 0.984199, "min": 0.541858}, "location": {"width": 992, "top": 839, "height": 37, "left": 117}, "words": "量:①第一次调整剂量:750mg,每日一次;②第二次调整剂量:500mg,每日一次(关于剂"}, {"probability": {"variance": 8.9e-05, "average": 0.996784, "min": 0.955155}, "location": {"width": 980, "top": 888, "height": 34, "left": 115}, "words": "量调整方法请参考下面表1及后续的【注意事项】)。如需要第三次调整剂量,则永久停药"}, {"probability": {"variance": 0.000173, "average": 0.994727, "min": 0.946617}, "location": {"width": 421, "top": 935, "height": 29, "left": 423}, "words": "表1.阿帕替尼治疗晚期胃癌的剂量调整原则"}, {"probability": {"variance": 0, "average": 0.618768, "min": 0.618768}, "location": {"width": 39, "top": 990, "height": 21, "left": 303}, "words": " NCI"}, {"probability": {"variance": 2e-06, "average": 0.998429, "min": 0.996106}, "location": {"width": 131, "top": 1007, "height": 27, "left": 136}, "words": "不良反应分类"}, {"probability": {"variance": 3e-06, "average": 0.998012, "min": 0.994238}, "location": {"width": 225, "top": 1003, "height": 36, "left": 654}, "words": "剂量调整的规定"}, {"probability": {"variance": 1e-05, "average": 0.996378, "min": 0.993282}, "location": {"width": 45, "top": 1029, "height": 26, "left": 302}, "words": "分级"}, {"probability": {"variance": 0.014391, "average": 0.967357, "min": 0.464174}, "location": {"width": 715, "top": 1071, "height": 30, "left": 371}, "words": "暂停用药,待不良反应恢复到≤2级,以原剂量继续用药。如再次由现3级或"}, {"probability": {"variance": 0, "average": 0.996146, "min": 0.996146}, "location": {"width": 21, "top": 1094, "height": 23, "left": 315}, "words": "级"}, {"probability": {"variance": 0, "average": 0.999748, "min": 0.999379}, "location": {"width": 150, "top": 1117, "height": 25, "left": 127}, "words": "血液学不良反应"}, {"probability": {"variance": 8.5e-05, "average": 0.99581, "min": 0.960501}, "location": {"width": 453, "top": 1098, "height": 44, "left": 372}, "words": "以上不良反应,则下调一个剂量后继续用药。"}, {"probability": {"variance": 0.00792, "average": 0.975018, "min": 0.516993}, "location": {"width": 643, "top": 1159, "height": 27, "left": 315}, "words": "级暂停用药,待不良反应恢复到≤2级,下调一个剂量后继续用药"}, {"probability": {"variance": 9.9e-05, "average": 0.996774, "min": 0.942803}, "location": {"width": 716, "top": 1206, "height": 28, "left": 370}, "words": "暂停用药,待不良反应恢复到≤1级,以原剂量继续用药;如再次出现3级或"}, {"probability": {"variance": 4.5e-05, "average": 0.993777, "min": 0.981188}, "location": {"width": 215, "top": 1225, "height": 38, "left": 125}, "words": "非血液学不良反3级"}, {"probability": {"variance": 1e-06, "average": 0.999385, "min": 0.994542}, "location": {"width": 407, "top": 1248, "height": 26, "left": 372}, "words": "以上不良反应,则下调一个剂量后继续用药"}, {"probability": {"variance": 0, "average": 0.99999, "min": 0.99999}, "location": {"width": 24, "top": 1279, "height": 23, "left": 126}, "words": "应"}, {"probability": {"variance": 0.003831, "average": 0.985162, "min": 0.659792}, "location": {"width": 645, "top": 1297, "height": 28, "left": 314}, "words": "级暂停用药,待不良反应恢复到≤1级,下调一个剂量后继续用药"}, {"probability": {"variance": 0.001478, "average": 0.990125, "min": 0.810983}, "location": {"width": 915, "top": 1340, "height": 29, "left": 153}, "words": "注:以上采用美国国家癌症研究所指定的常见药物毒性反应分级标准( nci-ctcae4.0)进行评价"}, {"probability": {"variance": 0.00288, "average": 0.99007, "min": 0.659349}, "location": {"width": 945, "top": 1383, "height": 31, "left": 162}, "words": "对于出现胃肠道穿孔、需要临床处理的伤口裂开、瘘、重度出血、肾病综合征或高血压危"}, {"probability": {"variance": 7e-06, "average": 0.997961, "min": 0.985434}, "location": {"width": 996, "top": 1432, "height": 34, "left": 112}, "words": "象的患者,应永久性地停用本品。尚需进一步确诊的中到重度蛋白尿或临床尚未控制的重度高"}, {"probability": {"variance": 6e-06, "average": 0.998104, "min": 0.991108}, "location": {"width": 920, "top": 1481, "height": 33, "left": 113}, "words": "血压患者,应暂时停止使用本品。择期手术之前,应暂缓本品使用(见【注意事项】)"}], "language": 3}